iOncologi
PrivateLast Round
Seed
May 23, 2025
Total Funding Raised
$3.25M
Company Overview
iOncologi, Inc. is a biotechnology company that develops immunotherapies for the treatment of refractory cancers and infectious diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
iOncologi Comparables
Compare iOncologi with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MimiVax Inc. | 83% | |
| Diakonos Oncology | 80% | |
| Hemispherian AS | 74% | |
iOncologi Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | May 23, 2025 |
iOncologi Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| UF Innovate | Ventures | Seed |
| University of Florida Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 22, 2026
Monthly visitors increased 60% MoM.
- May 23, 2025
$3.25M round led by UF Innovate | Ventures
iOncologi Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about iOncologi's valuation, stock price, and market status.